Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient

Recent advances in mass spectrometry (MS)‐based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Doll, Sophia, Kriegmair, Maximilian C., Santos, Alberto, Wierer, Michael, Coscia, Fabian, Neil, Helen Michele, Porubsky, Stefan, Geyer, Philipp E., Mund, Andreas, Nuhn, Philipp, Mann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068348/
https://www.ncbi.nlm.nih.gov/pubmed/29901861
http://dx.doi.org/10.1002/1878-0261.12326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068348/
https://www.ncbi.nlm.nih.gov/pubmed/29901861
http://dx.doi.org/10.1002/1878-0261.12326

Ejemplares similares